Potential of NOTCH1 Mutation to Predict Anti-PD1 Treatment Outcomes in Patients with Oesophageal Squamous Cell Cancer By Ogkologos - April 23, 2025 852 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a biomarker analysis from the RATIONALE-302 study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Data from a Large Cohort of Patients with mRCC Demonstrate the... September 21, 2020 New ESMO Framework to Resolve Uncertainties About the De-intensification of Cancer... May 9, 2022 New Way to Classify Meningioma Brain Tumors Suggests Potential Treatments June 17, 2022 Woman Has Unnecessary Double Mastectomy and Narrowly Avoids Hysterectomy After Bad... March 27, 2019 Load more HOT NEWS How can we diagnose more cancers earlier? Prognostic Significance of Lynch-like versus Sporadic MSI-H Endometrial Cancer Treated With... TAT 2021 Honorary Award: A Recognition in Cancer Drug Development to... More than 65,000 people are left waiting to find out if...
